Search

for
Search:

GlossaryIncretin Mimetics

mimic gut hormones to enhance insulin release in diabetes

Incretin mimetics are a class of medications used to treat type 2 diabetes by mimicking the action of incretin hormones, which stimulate insulin release in response to meals. These drugs help lower blood sugar levels by enhancing insulin secretion, slowing gastric emptying, and reducing appetite.

Related Terms

Research

5 / 1000+ results

research Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome

4 citations , January 2019 in “Therapeutic Advances in Endocrinology and Metabolism”

Medications for PCOS don't seem to raise heart disease risk.

research Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs

29 citations , September 2023 in “Journal of Clinical Medicine”

Semaglutide helps obese PCOS patients lose weight and improve health.

research The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

467 citations , October 2014 in “European Journal of Endocrinology”

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.